Alerus Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Alerus Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$3K	Buy	+46	New	+$2.9K	﹤0.01%	173

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alerus Investment Advisors's BMY Position: Q1 2016 in Review

Alerus Investment Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2016: 46 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #173 among its holdings.

1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Alerus Investment Advisors held 46 shares of Bristol-Myers Squibb worth $3K as of Q1 2016.
Bristol-Myers Squibb was a new Alerus Investment Advisors position in Q1 2016.
Bristol-Myers Squibb made up ﹤0.01% of Alerus Investment Advisors's portfolio in Q1 2016, its #173 holding.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.